Financials
- Market Capitalization 14.55 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-0.42
Rapporto prezzo/fatturato
3.49
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4704 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.34 USD | 0.00% | 0.00% | -10.53% | -73.85% | 16.52 M USD | ||
| 4714 | LEXX Lexaria Bioscience Corp. - Common Stock | 0.58 USD | -1.69% | +5.45% | -3.33% | -30.95% | 14.38 M USD | ||
| 4717 | AKTX Akari Therapeutics Plc - American Depositary Shares | 13.61 USD | +1.57% | -8.60% | +1.19% | +1126.13% | 15.58 M USD | ||
| 4728 | TPST Tempest Therapeutics, Inc. - Common Stock | 0.98 USD | 0.00% | -6.67% | -24.03% | -59.00% | 14.51 M USD |